Welcome to LookChem.com Sign In|Join Free
  • or
tert-Butyl glycinate, also known as glycine tert-butyl ester, is an organic compound derived from glycine, an amino acid. It is characterized by the presence of a tert-butyl group attached to the carboxylic acid group of glycine, which provides unique chemical properties and reactivity.

6456-74-2

Post Buying Request

6456-74-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6456-74-2 Usage

Uses

Used in Organic Synthesis:
tert-Butyl glycinate is used as a reagent in the preparation of Schiff bases. It reacts with benzophenone to form the Schiff base, which is an essential intermediate in the synthesis of various organic compounds.
Used in Asymmetric Alkylation:
The Schiff base derived from tert-Butyl glycinate undergoes asymmetric alkylation with arylmethyl bromides in the presence of O-allyl-N-(9-anthracenylmethyl)cinchonidinium bromide as a chiral phase transfer catalyst. This reaction leads to the formation of guanidine-containing pentacyclic compounds, which are valuable in the development of pharmaceuticals and other bioactive molecules.
Used in Pharmaceutical Industry:
tert-Butyl glycinate plays a crucial role in the synthesis of complex organic molecules, which are often used as active pharmaceutical ingredients. Its ability to participate in asymmetric alkylation reactions allows for the creation of enantiomerically pure compounds, which are essential for the development of effective and safe drugs.

Check Digit Verification of cas no

The CAS Registry Mumber 6456-74-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,4,5 and 6 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 6456-74:
(6*6)+(5*4)+(4*5)+(3*6)+(2*7)+(1*4)=112
112 % 10 = 2
So 6456-74-2 is a valid CAS Registry Number.
InChI:InChI=1/C6H13NO2/c1-6(2,3)9-5(8)4-7/h4,7H2,1-3H3

6456-74-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (L16258)  Glycine tert-butyl ester, 97%   

  • 6456-74-2

  • 1g

  • 518.0CNY

  • Detail
  • Alfa Aesar

  • (L16258)  Glycine tert-butyl ester, 97%   

  • 6456-74-2

  • 5g

  • 1994.0CNY

  • Detail

6456-74-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Tert-Butyl Glycinate

1.2 Other means of identification

Product number -
Other names tert-butyl 2-aminoacetate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6456-74-2 SDS

6456-74-2Synthetic route

tert-butyl N-(benzyloxycarbonyl)glycinate
16881-32-6

tert-butyl N-(benzyloxycarbonyl)glycinate

Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In ethanol92%
With hydrogen; palladium on activated charcoal In ethanol
With hydrogen; palladium on activated charcoal In methanol
bromoacetic acid tert-butyl ester
5292-43-3

bromoacetic acid tert-butyl ester

Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

Conditions
ConditionsYield
With ammonia In diethyl ether 1.) -40 deg C, 2 h, 2.) RT, overnight;90%
With ammonia In diethyl ether at -40℃;87%
With ammonia at -78℃; for 48h; Inert atmosphere;72%
With ammonia In diethyl ether at -40℃;70%
Multi-step reaction with 2 steps
1: aq. NaN3 / acetone
2: H2 / Pd-C / methanol
View Scheme
N-(9-fluorenylmethoxycarbonyl)glycine tert-butyl ester
35661-42-8

N-(9-fluorenylmethoxycarbonyl)glycine tert-butyl ester

Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

Conditions
ConditionsYield
With triethylamine; 1-butyl-3-methylimidazolium Tetrafluoroborate In neat (no solvent) at 25℃; Green chemistry;82%
(2,2,2-trichloro-ethoxycarbonylamino)-acetic acid tert-butyl ester
819050-60-7

(2,2,2-trichloro-ethoxycarbonylamino)-acetic acid tert-butyl ester

Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

Conditions
ConditionsYield
With 1-methyl-1H-imidazole; zinc In ethyl acetate for 6h;57%
tert-butyl methyl ether
1634-04-4

tert-butyl methyl ether

glycine
56-40-6

glycine

Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

Conditions
ConditionsYield
With sulfuric acid at 25℃; for 2h; Molecular sieve; chemoselective reaction;51%
Fms-Gly-OtBu
1245735-65-2

Fms-Gly-OtBu

Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

Conditions
ConditionsYield
With piperidine In N,N-dimethyl-formamide at 25℃; for 0.166667h;
N-(diphenylmethylene)glycine tert-butyl ester
81477-94-3

N-(diphenylmethylene)glycine tert-butyl ester

A

benzophenone
119-61-9

benzophenone

B

Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

Conditions
ConditionsYield
With cesiumhydroxide monohydrate In dichloromethane; toluene
N-(diphenylmethylene)glycine tert-butyl ester
81477-94-3

N-(diphenylmethylene)glycine tert-butyl ester

Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

Conditions
ConditionsYield
With cycl-isopropylidene malonate; water In ethyl acetate at 20℃; for 8h;
Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

benzaldehyde
100-52-7

benzaldehyde

tert-butyl N-benzylideneglycinate
64923-12-2

tert-butyl N-benzylideneglycinate

Conditions
ConditionsYield
With sodium sulfate In benzene Ambient temperature;100%
With trimethyl orthoformate for 8h;96%
With magnesium sulfate In benzene for 0.5h; Ambient temperature;75%
With magnesium sulfate In benzene
Stage #1: Glycine tert-butyl ester With magnesium sulfate; triethylamine In dichloromethane at 20℃; for 1h;
Stage #2: benzaldehyde In dichloromethane at 20℃;
Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

Z-Gly-L-Azy-Gly-OBzl
72087-11-7

Z-Gly-L-Azy-Gly-OBzl

A

N-carbobenzyloxy-glycyl-glycine tert-butyl ester
27375-61-7

N-carbobenzyloxy-glycyl-glycine tert-butyl ester

B

(2S)-H-Azy-Gly-OBzl
76314-24-4

(2S)-H-Azy-Gly-OBzl

Conditions
ConditionsYield
In dichloromethane for 24h; Ambient temperature;A 84.8%
B 100%
Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methyl-thiobutyric acid S-(2-formyl-4-nitro-phenyl) ester
557095-50-8

2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methyl-thiobutyric acid S-(2-formyl-4-nitro-phenyl) ester

Fmoc-Val-Gly-OtBu

Fmoc-Val-Gly-OtBu

Conditions
ConditionsYield
With N-methylmaleimide In phosphate buffer; N,N-dimethyl-formamide at 20℃; for 2.5h; pH=8.0;100%
Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

4-trifluorophenylsulfonyl chloride
2991-42-6

4-trifluorophenylsulfonyl chloride

tert-Butyl 2-(4-(trifluoromethyl)phenylsulfonamido)acetate
959997-92-3

tert-Butyl 2-(4-(trifluoromethyl)phenylsulfonamido)acetate

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 20℃; for 18h;100%
4,4-dimethylpentanal
926-36-3

4,4-dimethylpentanal

Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

2-[(E)-(3,3-dimethylbutylidene)amino]acetic acid tert-butyl ester
1219086-34-6

2-[(E)-(3,3-dimethylbutylidene)amino]acetic acid tert-butyl ester

Conditions
ConditionsYield
In dichloromethane at 20℃;100%
In dichloromethane at 20℃;
3,3-dimethylbutyrylaldehyde
2987-16-8

3,3-dimethylbutyrylaldehyde

Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

2-[(E)-(3,3-dimethylbutylidene)amino]acetic acid tert-butyl ester
1219086-34-6

2-[(E)-(3,3-dimethylbutylidene)amino]acetic acid tert-butyl ester

Conditions
ConditionsYield
In dichloromethane at 20℃;100%
In dichloromethane at 20℃;100%
In dichloromethane at 20℃;100%
Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

(N-benzyloxycarbonyl)-L-alanine N-hydroxysuccinimide ester
3401-36-3

(N-benzyloxycarbonyl)-L-alanine N-hydroxysuccinimide ester

tert-butyl ((benzyloxy)carbonyl)-L-alanylglycinate
13512-48-6

tert-butyl ((benzyloxy)carbonyl)-L-alanylglycinate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2h; Inert atmosphere;100%
With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2h; Inert atmosphere;
With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2h; Inert atmosphere;
1-chloro-4-methoxyisoquinoline-3-carboxylic acid
914672-45-0

1-chloro-4-methoxyisoquinoline-3-carboxylic acid

Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

tert-butyl 2-(1-chloro-4-methoxyisoquinoline-3-carboxamido)acetate

tert-butyl 2-(1-chloro-4-methoxyisoquinoline-3-carboxamido)acetate

Conditions
ConditionsYield
Stage #1: 1-chloro-4-methoxyisoquinoline-3-carboxylic acid With N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 20℃; for 0.166667h;
Stage #2: Glycine tert-butyl ester In N,N-dimethyl-formamide at 20℃; for 0.333333h;
Stage #3: With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide for 16h; Inert atmosphere;
100%
Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

C46H51N5O10

C46H51N5O10

C52H62N6O11

C52H62N6O11

Conditions
ConditionsYield
With benzotriazol-1-ol; O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at -5 - 20℃; Temperature;100%
Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

C69H75N5O18

C69H75N5O18

C75H86N6O19

C75H86N6O19

Conditions
ConditionsYield
Stage #1: Glycine tert-butyl ester; C69H75N5O18 With benzotriazol-1-ol; O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate at 0℃; for 0.333333h;
Stage #2: With N-ethyl-N,N-diisopropylamine at 0℃;
100%
Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

C68H73N5O18

C68H73N5O18

C74H84N6O19

C74H84N6O19

Conditions
ConditionsYield
Stage #1: Glycine tert-butyl ester; C68H73N5O18 With benzotriazol-1-ol; O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate In N,N-dimethyl-formamide at 0℃; for 0.5h;
Stage #2: With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide
100%
Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

(2'S,5R)-1-(1'-oxo-2'-phenylmethylpropyl)-3,3,5-trimethylpyrrolidin-2-one
155956-28-8

(2'S,5R)-1-(1'-oxo-2'-phenylmethylpropyl)-3,3,5-trimethylpyrrolidin-2-one

(2S)-N-tert-butoxycarbonylmethyl-2-phenylmethylpropanamide

(2S)-N-tert-butoxycarbonylmethyl-2-phenylmethylpropanamide

Conditions
ConditionsYield
for 120h;99%
at 20℃; for 120h;99%
Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

2,2,2-Trichloroethyl chloroformate
17341-93-4

2,2,2-Trichloroethyl chloroformate

(2,2,2-trichloro-ethoxycarbonylamino)-acetic acid tert-butyl ester
819050-60-7

(2,2,2-trichloro-ethoxycarbonylamino)-acetic acid tert-butyl ester

Conditions
ConditionsYield
With pyridine In tetrahydrofuran at 0 - 20℃;99%
BTZO-2
501375-54-8

BTZO-2

Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

tert-butyl ({3-[6-(4-Oxo-4H-1,3-benzothiazin-2-yl)-2-pyridyl]propanoyl }amino)acetate

tert-butyl ({3-[6-(4-Oxo-4H-1,3-benzothiazin-2-yl)-2-pyridyl]propanoyl }amino)acetate

Conditions
ConditionsYield
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 17h;99%
Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

benzyl chloroformate
501-53-1

benzyl chloroformate

benzyloxycarbonyl-amino acetic acid tert-butyl ester

benzyloxycarbonyl-amino acetic acid tert-butyl ester

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 0℃; for 3h;99%
2,2-dimethyl-4-oxobutyronitrile
18240-73-8

2,2-dimethyl-4-oxobutyronitrile

Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

tert-butyl (E)-2-(3-cyano-3-methylbutylideneamino)acetate

tert-butyl (E)-2-(3-cyano-3-methylbutylideneamino)acetate

Conditions
ConditionsYield
In dichloromethane at 20℃;98.8%
Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

Allyloxycarbonylamino-acetic acid (3aR,5R,6S,6aR)-5-dimethylaminomethyl-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-6-yl ester
145147-49-5

Allyloxycarbonylamino-acetic acid (3aR,5R,6S,6aR)-5-dimethylaminomethyl-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-6-yl ester

Aloc-Gly-Gly-OtBu
145147-53-1

Aloc-Gly-Gly-OtBu

Conditions
ConditionsYield
lithium bromide In dichloromethane at 20℃; for 24h;98%
lithium bromide In dichloromethane at 20℃; for 24h; Rate constant; other carbohydrate ester of N-protected amino acids, other amino acid esters; uncatalyzed reaction;98%
Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

6-methyl-2,4-pyrimidine-diyl dibenzoate
155632-06-7

6-methyl-2,4-pyrimidine-diyl dibenzoate

A

6-Methyluracil
626-48-2

6-Methyluracil

B

hippuric acid tert-butyl ester
19811-56-4

hippuric acid tert-butyl ester

Conditions
ConditionsYield
In dichloromethane for 0.5h; Heating;A n/a
B 98%
Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

(1S)-N,N-bis(1-methylethyl)-7,7-dimethyl-2-thioxobicyclo[2.2.1]heptane-1-methanesulfonamide
213532-59-3

(1S)-N,N-bis(1-methylethyl)-7,7-dimethyl-2-thioxobicyclo[2.2.1]heptane-1-methanesulfonamide

(1S)-1,1-dimethylethyl 2-(N,N-bis(1-methylethyl)-7,7-dimethyl-1-methanesulfonamidobicyclo[2.2.1]hept-2-ylideneamino)ethanoate

(1S)-1,1-dimethylethyl 2-(N,N-bis(1-methylethyl)-7,7-dimethyl-1-methanesulfonamidobicyclo[2.2.1]hept-2-ylideneamino)ethanoate

Conditions
ConditionsYield
In toluene for 48h; Heating;98%
Benzophenone imine
1013-88-3

Benzophenone imine

Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

N-(diphenylmethylene)glycine tert-butyl ester
81477-94-3

N-(diphenylmethylene)glycine tert-butyl ester

Conditions
ConditionsYield
In dichloromethane at 20℃; for 24h;98%
Glycine tert-butyl ester
6456-74-2

Glycine tert-butyl ester

(2R,3S)-3-endo-benzyloxycarbonyl-bicyclo[2.2.1]hept-5-ene-2-endo-carboxylic acid
581100-26-7

(2R,3S)-3-endo-benzyloxycarbonyl-bicyclo[2.2.1]hept-5-ene-2-endo-carboxylic acid

(2S,3R)-3-endo-(1-tert-butoxycarbonyl-methylcarbamoyl)bicyclo[2.2.1]hept-5-ene-2-endo-carboxylic acid benzyl ester

(2S,3R)-3-endo-(1-tert-butoxycarbonyl-methylcarbamoyl)bicyclo[2.2.1]hept-5-ene-2-endo-carboxylic acid benzyl ester

Conditions
ConditionsYield
With dmap; benzotriazol-1-ol; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide In dichloromethane at 0 - 20℃; for 13h;98%

6456-74-2Relevant academic research and scientific papers

Preparation method of tert-butyl glycine

-

, (2021/11/06)

The invention discloses a preparation method of tert-butyl glycine, and belongs to the technical field of organic synthesis. The raw materials are easily available, the process is simple, the process is simple, the reaction conditions are mild, the requirement for equipment is low, the total yield is up to 85 - 93%, and a significant amount of double-substituted by-products are effectively avoided in the direct reaction with ammonia in the traditional process.

A General Stereocontrolled Synthesis of Opines through Asymmetric Pd-Catalyzed N-Allylation of Amino Acid Esters

Albat, Dominik,Neud?rfl, J?rg-Martin,Schmalz, Hans-Günther

supporting information, p. 2099 - 2102 (2021/07/22)

A stereo-divergent synthesis of natural and unnatural opines in stereochemically pure form is based on the direct palladium-catalyzed N-allylation of α-amino acid esters (up to 97 % ee or 99 : 1 d.r.) using methyl (E)-2-penten-4-yl carbonate in the presence of only 1 mol% of a catalyst, prepared in-situ from the C2-symmetric diphosphine iPr-MediPhos and [Pd(allyl)Cl]2. Selected target compounds (incl. a derivative of the drug enalapril) were efficiently obtained from the N-allylated intermediates by oxidative cleavage (ozonolysis) of the allylic C=C bond under temporary N-Boc-protection.

Single Electron Transfer-Induced Selective α-Oxygenation of Glycine Derivatives

Císa?ová, Ivana,Jahn, Ullrich,K?nig, Burkhard,Moser, Johannes,Venugopal, Navyasree,Vojtí?ková, Margaréta

supporting information, (2021/11/03)

Modification of amino acids is an important strategy in organic and bioorganic chemistry. In contrast to common side-chain functionalization, backbone modification is much less explored. Especially glycine units seem to be attractive and versatile since a wide range of functionality can be potentially introduced. We report here oxidative modification of glycinates that are stable and enable further functionalization. Selective glycinate enolate oxidation by TEMPO or a FeCp2PF6/TEMPO reagent combination provides stable alkoxyamines in good to excellent yields. The methodology is expanded to glycine-containing dipeptides demonstrating selective oxygenation at the glycine unit. The orthogonal reactivity potential of oxygenated glycines for transformation to other amino acid derivatives is explored.

Overcoming the Deallylation Problem: Palladium(II)-Catalyzed Chemo-, Regio-, and Stereoselective Allylic Oxidation of Aryl Allyl Ether, Amine, and Amino Acids

Begam, Hasina Mamataj,Jana, Ranjan,Manna, Kartic,Samanta, Krishanu

supporting information, p. 7443 - 7449 (2020/10/09)

We report herein a Pd(II)/bis-sulfoxide-catalyzed intramolecular allylic C-H acetoxylation of aryl allyl ether, amine, and amino acids with the retention of a labile allyl moiety. Mechanistically, the reaction proceeds through a distinct double-bond isomerization from the allylic to the vinylic position followed by intramolecular carboxypalladation and the β-hydride elimination pathway. For the first time, C-H oxidation of N-allyl-protected amino acids to furnish five-membered heterocycles through 1,3-syn-addition is established with excellent diastereoselectivity.

Multicomponent synthesis of pyroglutamic acid derivatives: Via Knoevenagel-Michael-hydrolysis-lactamization-decarboxylation (KMHL-D) sequence

Khopade, Tushar M.,Warghude, Prakash K.,Sonawane, Amol D.,Bhat, Ramakrishna G.

supporting information, p. 561 - 566 (2019/01/24)

A novel and practical method for the synthesis of 3-substituted pyroglutamic acid derivatives is described. One pot multicomponent reaction of Meldrum's acid, aldehyde and Schiff's base followed an unprecedented chemoselective Knoevenagel-Michael-hydrolysis-lactamization domino sequence to afford 4-carboxy 3-substituted pyroglutamic acid derivatives under mild conditions. A carboxy intermediate formed appears to accelerate its own formation. The generality of the synthesis is exemplified by the use of a wide variety of aldehydes including enolizable aliphatic aldehydes, while substrates are stable under reaction conditions.

Simple and efficient Fmoc removal in ionic liquid

Di Gioia,Costanzo,De Nino,Maiuolo,Nardi,Olivito,Procopio

, p. 36482 - 36491 (2017/08/02)

A mild method for an efficient removal of the fluorenylmethoxycarbonyl (Fmoc) group in ionic liquid was developed. The combination of a weak base such as triethylamine and [Bmim][BF4] makes the entire system more efficient for the cleavage at room temperature of various amines and amino acid methyl esters in short reaction times. The procedure works well even in the case of N-Fmoc amino acids bearing acid-sensitive protecting groups and of N-alkylated amino acid methyl esters. The solvent-free condition provides a complementary method for Fmoc deprotection in solution phase peptide synthesis and modern organic synthesis.

Efficient Synthesis of 11C-Acrylesters, 11C-Acrylamides and Their Application in Michael Addition Reactions for PET Tracer Development

Filp, Ulrike,Pees, Anna L.,Taddei, Carlotta,Peko?ak, Aleksandra,Gee, Antony D.,Windhorst, Albert D.,Poot, Alex J.

supporting information, p. 5154 - 5162 (2017/09/20)

Here we present a new Michael addition reaction utilizing carbon-11 labeled acrylic esters and amides. Subsequently, reactions of these synthons with commercially available Schiff base precursors are performed to produce [11C]glutamate and [11C]glutamine. This methodology is especially useful for the development of positron emission tomography (PET) imaging agents as it offers a new array of potential carbon-11 labeled compounds with this original 11C–C bond forming strategy.

Total synthesis of (-)-platensimycin by advancing oxocarbenium- and iminium-mediated catalytic methods

Eey, Stanley T.-C.,Lear, Martin J.

, p. 11556 - 11573 (2015/01/16)

(-)-Platensimycin is a potent inhibitor of fatty acid synthase that holds promise in the treatment of metabolic disorders (e.g., diabetes and "fatty liver") and pathogenic infections (e.g., those caused by drug-resistant bacteria). Herein, we describe its total synthesis through a four-step preparation of the aromatic amine fragment and an improved stereocontrolled assembly of the ketolide fragment, (-)-platensic acid. Key synthetic advances include 1) a modified Lieben haloform reaction to directly convert an aryl methyl ketone into its methyl ester within 30 seconds, 2) an experimentally improved dialkylation protocol to form platensic acid, 3) a sterically controlled chemo- and diastereoselective organocatalytic conjugate reduction of a spiro-cyclized cyclohexadienone by using the trifluoroacetic acid salt of α-amino di-tert-butyl malonate, 4) a tetrabutylammonium fluoride promoted spiro-alkylative para dearomatization of a free phenol to assemble the cagelike ketolide core with the moderate leaving-group ability of an early tosylate intermediate, and 5) a bismuth(III)-catalyzed Friedel-Crafts cyclization of a free lactol, with LiClO4 as an additive to liberate a more active oxocarbenium perchlorate species and suppress the Lewis basicity of the sulfonyloxy group. The longest linear sequence is 21 steps with an overall yield of 3.8% from commercially available eugenol. Relay tactics: The stereocontrolled assembly of the potent antibiotic (-)-platensimycin in 21 steps and 3.8% yield from eugenol is described (see scheme; TBAF: tetrabutylammonium fluoride; Ts: toluene-4-sulfonyl). Highlights are 1) a rapid oxidative esterification of an acyl aromatic, 2) a reliable dialkylation protocol to form platensic acid, 3) a π-facial conjugate reduction of a dienone, 4) a TBAF-promoted alkylative dearomatization of a free phenol, and 5) a Friedel-Crafts closure of a free lactol.

Chiral iminoesters derived from d-glyceraldehyde in [3+2] cycloaddition reactions. Asymmetric synthesis of a key intermediate in the synthesis of neuramidinase inhibitors

Galvez, Jose A.,Diaz-De-Villegas, Maria D.,Alias, Miriam,Badorrey, Ramon

, p. 11404 - 11413 (2013/12/04)

Silver-catalyzed endo-selective and copper-catalyzed exo-selective asymmetric [3 + 2] cycloadditions of acrylates to chiral iminoesters derived from d-glyceraldehyde have been investigated. The reaction diastereoselectively provides highly functionalized pyrrolidines. This approach was used to develop the first asymmetric synthesis of a key intermediate in the synthesis of pyrrolidine influenza neuramidinase inhibitors.

Toward the selective delivery of chemotherapeutics into tumor cells by targeting peptide transporters: Tailored gold-based anticancer peptidomimetics

Negom Kouodom, Morelle,Ronconi, Luca,Celegato, Marta,Nardon, Chiara,Marchiò, Luciano,Dou, Q. Ping,Aldinucci, Donatella,Formaggio, Fernando,Fregona, Dolores

scheme or table, p. 2212 - 2226 (2012/05/05)

Complexes [AuIIIX2(dtc-Sar-AA-O(t-Bu))] (AA = Gly, X = Br (1)/Cl (2); AA = Aib, X = Br (3)/Cl (4); AA = l-Phe, X = Br (5)/Cl (6)) were designed on purpose in order to obtain gold(III)-based anticancer peptidomimetics that might specifically target two peptide transporters (namely, PEPT1 and PEPT2) upregulated in several tumor cells. All the compounds were characterized by means of FT-IR and mono- and multidimensional NMR spectroscopy, and the crystal structure of [AuIIIBr2(dtc-Sar-Aib-O(t- Bu))] (3) was solved and refined. According to in vitro cytotoxicity studies, the Aib-containing complexes 3 and 4 turned out to be the most effective toward all the human tumor cell lines evaluated (PC3, DU145, 2008, C13, and L540), reporting IC50 values much lower than that of cisplatin. Remarkably, they showed no cross-resistance with cisplatin itself and were proved to inhibit tumor cell proliferation by inducing either apoptosis or late apoptosis/necrosis depending on the cell lines. Biological results are here reported and discussed in terms of the structure-activity relationship.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 6456-74-2